Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

Myriad Genetics Inc. (MYGN)

-NasdaqGS
36.10 Down 0.62(1.69%) Jul 31, 3:59PM EDT
|After Hours : 36.10 0.00 (0.00%) Jul 31, 4:32PM EDT
Prev Close:36.72
Open:36.42
Bid:36.09 x 200
Ask:36.10 x 400
1y Target Est:39.00
Beta:0.97
Next Earnings Date:12-Aug-14MYGN Earnings announcement
Day's Range:35.80 - 37.33
52wk Range:20.02 - 42.50
Volume:517,118
Avg Vol (3m):1,069,180
Market Cap:2.70B
P/E (ttm):15.31
EPS (ttm):2.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MYGNDown 1.69%2.70B
ABTDown 1.73%63.26B

Key Statistics

Forward P/E (1 yr):16.87
P/S (ttm):3.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-14) :2.39
Quarterly EPS Est (Jun-14) :0.46
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):1.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback